Your browser doesn't support javascript.
loading
Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities.
Estadt, Angela T; Miller, William C; Kline, David; Whitney, Bridget M; Young, April M; Todd Korthuis, P; Stopka, Thomas J; Feinberg, Judith; Zule, William A; Pho, Mai T; Friedmann, Peter D; Westergaard, Ryan P; Eagen, Kellene V; Seaman, Andrew; Ma, Jimmy; Go, Vivian F; Lancaster, Kathryn E.
Afiliación
  • Estadt AT; Ohio State University, College of Public Health, Division of Epidemiology, United States. Electronic address: estadt.24@osu.edu.
  • Miller WC; Ohio State University, College of Public Health, Division of Epidemiology, United States; Department of Epidemiology, University of North Carolina at Chapel Hill, Gillings School of Global Public Health, Chapel Hill, North Carolina, United States of America.
  • Kline D; Wake Forest University School of Medicine, Division of Public Health Sciences, Department of Biostatistics and Data Science, United States.
  • Whitney BM; University of Washington, Department of Medicine, United States.
  • Young AM; University of Kentucky, Department of Epidemiology and Environmental Health, Center on Drug and Alcohol Research, United States.
  • Todd Korthuis P; Oregon Health & Science University, Department of Medicine, Section of Addiction Medicine, United States.
  • Stopka TJ; Department of Public Health and Community Medicine, Tufts University School of Medicine, United States.
  • Feinberg J; West Virginia University School of Medicine, Departments of Behavioral Medicine and Psychiatry and Medicine/Infectious Diseases, United States.
  • Zule WA; RTI International, Research Triangle Park, NC, United States.
  • Pho MT; University of Chicago, Department of Medicine, United States.
  • Friedmann PD; University of Massachusetts Medical School-Baystate and Baystate Health, United States.
  • Westergaard RP; University of Wisconsin School of Medicine and Public Health, Department of Medicine, Division of Infectious Diseases, United States.
  • Eagen KV; University of Wisconsin - Madison, School of Medicine and Public Health, Department of Family Medicine and Community Health, United States.
  • Seaman A; Oregon Health & Science University, School of Medicine, United States.
  • Ma J; University of Washington, Department of Medicine, Division of Allergy and Infectious Diseases, United States.
  • Go VF; University of North Carolina at Chapel Hill, Gillings School of Global Public Health, Department of Health Behavior, United States.
  • Lancaster KE; Ohio State University, College of Public Health, Division of Epidemiology, United States; Division of Public Health Sciences, Department of Implementation Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States of America.
Int J Drug Policy ; : 104222, 2023 Oct 06.
Article en En | MEDLINE | ID: mdl-37806839
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int J Drug Policy Asunto de la revista: SAUDE PUBLICA / TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2023 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int J Drug Policy Asunto de la revista: SAUDE PUBLICA / TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2023 Tipo del documento: Article Pais de publicación: Países Bajos